Next time someone says vaccine developers dont make money send them this. Vaccine manufacturers made an average of US$100 Million each in 2011. Sanofi Pasteur 200-2011-38199 $1,142,400,000.00 [1] GlaxoSmithKline 200-2011-38201 $786,456,400.00 [2] Merck 200-2011-38200 $1,704,454,000.00 [3] Novartis 200-2011-38204 $451,660,000.00 [4] Pfizer 200-2011-38203 $1,652,570,000.00 [5] MassBiologics 200-2011-38202 $11,250,000.00 [6] Total $5,748,790,400.00 The World Health Organization (WHO) website discusses how vaccine prices are establish. “Vaccine production costs have a significant fixed cost component, reaching up to 90 percent of total costs. These costs include research and development (R&D), quality control and quality assurance, selling and distribution overhead, and the construction and maintenance of production facilities.” [7] If it is assumed that costs remain the same – ignoring improved efficiency in R&D, manufacturing, reduced vaccine taxes, etc. – the remaining 10% is pharmaceutical company profit. 10% profit of 5.7 billion dollars is an average of US$100 Million dollars per company. NB. These are the figures for the federal Vaccines For Children (VFC) program, the total amount for all vaccines will be much higher. 1. Contract Award for Sanofi Pasteur https://fbo.gov/index?s=opportunity&mode=form&tab=core&id=9c6e25873f0cdaa9220b6f9a4d3f59e0 2. Contract Award for GlaxoSmithKline https://fbo.gov/index?s=opportunity&mode=form&id=8d9318e0064e03d202bd4e82201fba56&tab=core&_cview=0 3. Contract Award for Merck https://fbo.gov/index?s=opportunity&mode=form&id=d0f96e01f7c99849184ebae2280d47cf&tab=core&_cview=0 4. Contract Award for Novartis https://fbo.gov/index?s=opportunity&mode=form&id=c4bfebe64d04bd0a9342fd51d736fd77&tab=core&_cview=0 5. Contract Award for Pfizer https://fbo.gov/index?s=opportunity&mode=form&id=81727165b87a75be1ed4d24b292e3fda&tab=core&tabmode=list& 6. Contract Award for Mass Biologics https://fbo.gov/index?s=opportunity&mode=form&id=bb75e52010be266964a8992c2d21c43c&tab=core&_cview=0 7. who.int/immunization_financing/options/en/briefcase_vacproduction.pdf
Posted on: Fri, 14 Mar 2014 12:25:33 +0000
Trending Topics
Recently Viewed Topics
© 2015